patients aged ≥ 20 years at the time of informed consent

japanese patients with type 2 diabetes

patients who have hba1c ≥ 7.0% and < 10.0% if untreated with antidiabetic agent.

patients who have hba1c ≥ 6.5% and < 9.5% if treated with antidiabetic agent.

patients aged ≥ 70 years at the time of informed consent

patients with a history of type 1 diabetes or diabetic ketoacidosis

patients receiving or requiring treatment with insulin

patients with a body mass index (bmi) of < 18.5 kg/m2 or ≥ 35.0 kg/m2

patients with an estimated glomerular filtration rate (egfr), < 45 ml/min per 1.73 m2

patients with fasting plasma glucose ≥ 240 mg/dl